<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00995852</url>
  </required_header>
  <id_info>
    <org_study_id>09 2009</org_study_id>
    <nct_id>NCT00995852</nct_id>
  </id_info>
  <brief_title>Unilateral Versus Bilateral Endoscopic Lung Volume Reduction A Comparative Case Study</brief_title>
  <official_title>Unilateral vs. Bilateral IBV Placement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Spiration, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with bilateral heterogeneous pulmonary emphysema benefit to differing degrees from
      unilateral ELVR with complete lobe closure in comparison with incomplete bilateral treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patient enrolment and data acquisition is to be carried out on a prospective basis. It is
      planned to enrol a total of 20 patients with bilateral heterogeneous pulmonary emphysema. All
      patients will undergo treatment at one study centre in Heidelberg. Patients will be
      considered for both unilateral and bilateral treatment with intrabronchial valves (IBV) on
      the basis of their emphysema distribution. Patients will be randomised to two treatment arms.
      10 patients receive unilateral or bilateral treatment in each case.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">May 2011</completion_date>
  <primary_completion_date type="Anticipated">May 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in pulmonary function (FEV1) 6-minute walking test</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of major complications(SAE)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the IBV migration rate</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average changes in quality of life (SGRQ)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average changes in pulmonary function (FEV1, IVC, RV, TLC, RV/TLC)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pulmonary Emphysema</condition>
  <arm_group>
    <arm_group_label>bilateral</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment arm B - incomplete bilateral treatment of in total two lobes (contralateral).
The study will only use Intrabronchial Valvesâ„¢</description>
  </arm_group>
  <arm_group>
    <arm_group_label>unilateral</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment arm A - unilateral treatment with complete closure of the worst lobe of the lungs</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IBV Implantation</intervention_name>
    <description>In severe cases of COPD even optimum treatment involving bronchodilatation with drugs, physical training and possibly oxygen therapy is unable to influence exercise capacity and the perception of dyspnoea to a sufficient extent. Given the assumption that the elastic recoil of the small airways can be improved by a reduction in lung volume and pulmonary function overall by more ergonomic breathing mechanics and diaphragm function, various endoscopic procedures for lung volume reduction are available. Here one of the most advanced techniques is the implantation of intrabronchial valves. The one-way mechanism of this valve allows air to escape from the downstream lung segment without any influx of &quot;new&quot; air during inspiration</description>
    <arm_group_label>unilateral</arm_group_label>
    <other_name>Spiration IBV</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IBV Implantation</intervention_name>
    <description>In severe cases of COPD even optimum treatment involving bronchodilatation with drugs, physical training and possibly oxygen therapy is unable to influence exercise capacity and the perception of dyspnoea to a sufficient extent. Given the assumption that the elastic recoil of the small airways can be improved by a reduction in lung volume and pulmonary function overall by more ergonomic breathing mechanics and diaphragm function, various endoscopic procedures for lung volume reduction are available. Here one of the most advanced techniques is the implantation of intrabronchial valves. The one-way mechanism of this valve allows air to escape from the downstream lung segment without any influx of &quot;new&quot; air during inspiration</description>
    <arm_group_label>bilateral</arm_group_label>
    <other_name>Spiration IBV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 40 inhomogeneous emphysema FEV1 between 20-40% DLCO between 20-40% 6MWT &gt; 150 m

        Exclusion Criteria:

          -  pregnant homogeneous disease FEV1 &lt; 20%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felix JF Herth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heidelberg University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Felix JF Herth, MD</last_name>
    <phone>+49 6221 396</phone>
    <phone_ext>1200</phone_ext>
    <email>Felix.Herth@thoraxklinik-heidelberg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ralf Eberhardt, MD</last_name>
    <phone>+49 6221 396</phone>
    <phone_ext>1204</phone_ext>
    <email>Ralf.Eberhardt@rthoraxklinik-heidelberg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Thoraxklinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix JF Herth, MD</last_name>
      <phone>+49 6221 396</phone>
      <phone_ext>1200</phone_ext>
      <email>Felix.Herth@thoraxklinik-heidelberg.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Venuta F, Rendina EA, Coloni GF. Endobronchial treatment of emphysema with one-way valves. Thorac Surg Clin. 2009 May;19(2):255-60, x. doi: 10.1016/j.thorsurg.2009.04.002. Review.</citation>
    <PMID>19662969</PMID>
  </reference>
  <reference>
    <citation>Chan KM, Martinez FJ, Chang AC. Nonmedical therapy for chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009 Jan 15;6(1):137-45. doi: 10.1513/pats.200809-114GO. Review.</citation>
    <PMID>19131539</PMID>
  </reference>
  <reference>
    <citation>Ingenito EP, Wood DE, Utz JP. Bronchoscopic lung volume reduction in severe emphysema. Proc Am Thorac Soc. 2008 May 1;5(4):454-60. doi: 10.1513/pats.200707-085ET. Review.</citation>
    <PMID>18453355</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2009</study_first_submitted>
  <study_first_submitted_qc>October 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2009</study_first_posted>
  <last_update_submitted>April 26, 2011</last_update_submitted>
  <last_update_submitted_qc>April 26, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 27, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Felix JF Herth</name_title>
    <organization>Thoraxklinik Heidelberg</organization>
  </responsible_party>
  <keyword>Endoscopic lung volume reduction</keyword>
  <keyword>emphysema</keyword>
  <keyword>COPD</keyword>
  <keyword>Patients with bilateral heterogeneous pulmonary emphysema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

